EMPA-Q 25mg TABLETS EMPAGLIFLOZIN 20’S

Empa-Q Tablets, containing Empagliflozin 25mg, are a prescription medication primarily used for the management of type 2 diabetes mellitus. This drug works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion in urine and consequently lowering blood sugar levels. In addition to its primary use in diabetes management, Empagliflozin has been shown to provide cardiovascular benefits, reducing the risk of heart failure and improving overall heart health in diabetic patients.

Empa-Q Tablets are typically prescribed alongside a healthy diet and exercise regimen to enhance glycemic control. They are also beneficial for patients with chronic kidney disease associated with diabetes. In Kenya, the growing prevalence of diabetes makes Empa-Q an essential option for healthcare providers aiming to improve patient outcomes. Always consult a healthcare professional before starting any new medication.